Hilton’s asset-light model, global reach, and strong Q2 2025 results support steady growth despite macro pressures and ...

CGDV has outpaced the S&P 500 by 70% in fiscal 2025 and is emerging as a leading dividend ETF since its 2022 launch. See why ...

The first half of the year was characterized by dramatic swings in the markets, both in terms of price movements and ...

Cigna stock trades at a 15% discount, offering an entry point despite mixed Q2 results. Read here for an investment analysis ...

Global X SuperDividend ETF empirical performance consistently underperforms peers. See why SDIV's high yield may not deliver ...

Pfizer beats Q2 estimates with $14.7B revenue and $0.78 EPS. Management showed extreme confidence by raising full-year EPS ...

Read here for insights on Waterdrop (WDP) stock's revenue growth, innovative insurance products, and company outlook amid ...

BioSig Technologies pivots to blockchain with a focus on tokenized Gold after past struggles in medtech and a merger with ...

The idea behind the InfraCap REIT Preferred ETF is simple: gain exposure to real estate-linked cash flows, but with a higher ...

Managers see the largest mega-cap growth stocks as crowded trades, with many holding less exposure due to high valuations and ...

Oscar Health has a lot of opportunities with the growth of Health Reimbursement Arrangements. See why OSCR stock is a buy ...

Blue Owl Capital saw continued double-digit growth in net investment income. See why OBDC is a top pick for income investors.